NSE filing, NSE: CELLPOINT. Summary written from the filing by ALFA Finder's alert engine.
Cell Point (India) Ltd: key numbers
- Share price
- ₹15.95
- Market cap
- ₹29.80 Cr
- Revenue (annual)
- ₹367.9 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 469.4×Sector 61.5×
- Promoter holding
- 73.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cell Point (India) Ltd
All →Cell Point (India) Other Announcement
Cell Point (India) Limited submitted a certificate for the quarter ended September 30, 2026, confirming Regulation 74(5) is not applicable to the company.
Cell Point (India) Annual General Meeting
Cell Point (India) Limited conducted its 13th Annual General Meeting on September 29, 2026. Shareholders considered resolutions for adoption of financial statements and director re-appointments.
Cell Point (India) Annual Report
Cell Point (India) Limited issued a corrigendum to its FY 2025-26 Annual Report, including the previously omitted Form AOC-2. The revised report is available online.
Cell Point (India) Annual General Meeting
Cell Point (India) Limited has scheduled its 13th Annual General Meeting for September 29, 2026. The company fixed September 22, 2026, as the record date for voting.
Cell Point (India) Management Change
Cell Point (India) Limited announced the re-appointment of Mr. Mohan Prasad Panday as Managing Director and Mr. Bala Balaji Panday as Whole Time Director for five years.
- Execution
- 5 years
Cell Point (India) Financial Results
Cell Point (India) Ltd resubmitted its unaudited half‑year 2025 financial results and clarified EPS discrepancies. The submission satisfies the exchange's clarification request.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.